Forest Laboratories Inc (NYSE:FRX - News) plans to nominate a 10-person board slate that includes three new members at its shareholder meeting, as the drugmaker fends off a challenge from billionaire investor Carl Icahn. In addition to seven incumbents, Forest plans to nominate Christopher Coughlin, former chief financial officer of Tyco International Ltd (NYSE:TYC - News); Gerald Lieberman, former president of AllianceBernstein Holding LP (NYSE:AB - News); and Brenton Saunders, CEO of eye-care company Bausch & Lomb. Previously, Forest’s board had had nine members.
